4.300USD+0.70%Mkt Cap: 33.53M USDP/E: —Last update: 2026-06-01
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that r…
Industry Peers
Computer Hardware299.63BUSDP/E 53.2
259.25BUSDP/E 59.7
215.34BUSDP/E 59.0
187.57BUSDP/E 32.5
28.43BUSDP/E 24.9
27.82BUSDP/E 126.9
26.85BUSDP/E 10.9
26.65BUSDP/E 183.1
Indicators:|
Key Statistics
Company
Market Cap33.53M USD
Enterprise Value24.54M USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)-11.63M USD
Revenue/Share—
Last Price4.300 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2
CountryUS
SectorTechnology
IndustryComputer Hardware
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.67
EPS (TTM)-8.49
EPS (Forward)—
52W Range
2.5006% of range33.60
52W High33.60 USD
52W Low2.500 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-53.45%
ROA-28.24%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.07M USD
CapEx (TTM)2.01M USD
FCF Margin—
FCF Yield-19.51%
Net Debt-12.97M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.00
Current Ratio3.71
Quick Ratio3.52
Book Value/Sh2.620 USD
Cash/Share1.652 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateSep 2, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.7.85M
Float7.78M
Insiders4.35%
Institutions7.99%
Short Interest
Short Ratio3.0d
Short % Float119.36%
Short % Out.22.10%
Shares Short1.74M
Short (prev mo.)1.30M
Technical
SMA 503.823 (+12.5%)
SMA 2004.377 (-1.8%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)560.54K
Avg Vol (10d)930.60K
Technical Indicators
RSI (14)54.0
MACD0.1090
MACD Signal0.0936
MACD Hist.+0.0155
BB Upper4.732 USD
BB Middle4.051 USD
BB Lower3.369 USD
BB Width33.63%
ATR (14)0.4502 USD
Vol Ratio (20d)0.72x